{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-048684","form_type":"8-K","ticker":"BEAM","cik":"0001745999","company_name":"Beam Therapeutics Inc.","filed_at":"2026-02-12T23:59:59+00:00","discovered_at":"2026-05-14T18:02:36.059857+00:00","generated_at":"2026-05-16T03:05:00.606936+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Beam Therapeutics secures standby direct license to Kobe University patents for base editing","bullets":["Agreement dated Feb 9, 2026 among Beam, Bio Palette, and Kobe University ensures backup patent access.","If Kobe-Bio Palette license terminates (barring Beam-caused breach), Kobe grants Beam an exclusive direct license.","Beam will pay Kobe the same amounts it would have paid Bio Palette under the original sublicense.","Beam assumes prosecution and maintenance costs for Kobe patents after the effective time.","Standby license covers the same scope as Beam's current sublicense from Bio Palette."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-048684","json":"https://secwatch.observer/filing/0001193125-26-048684.json","markdown":"https://secwatch.observer/filing/0001193125-26-048684.md","text":"https://secwatch.observer/filing/0001193125-26-048684.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1745999/000119312526048684/0001193125-26-048684-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1745999/000119312526048684/beam-20260209.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T03:05:00.606936+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"d9ccdcb4e9ac4a6635f490f274e2b7e0c931f925","claim":"Beam Therapeutics Inc. entered into Standby License Agreement with Kobe University and Bio Palette Co., Ltd. (effective 2026-02-09).","evidence_excerpt":"on February 9, 2026, the Company entered into a standby license agreement (the “Standby License Agreement”) with Kobe and Bio Palette.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1745999/000119312526048684/0001193125-26-048684-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"license"},{"label":"Counterparty","value":"Kobe University and Bio Palette Co., Ltd."},{"label":"Effective","value":"2026-02-09"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}